跳至主要內容

藥物交互作用

Efgartigimod / hyaluronidase sc + Galcanezumab

嚴重程度: 中度

Efgartigimod / hyaluronidase sc and Galcanezumab: moderate interaction.

最後更新

僅供醫療專業人員參考。本頁為簡要摘要,並非醫療建議,亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。

本頁的臨床內容僅提供英文版。

摘要

Efgartigimod blocks the neonatal Fc receptor, which normally recycles IgG and prolongs its half-life. Galcanezumab is an IgG4 antibody, so exposure and migraine prevention could be reduced. Clinical data for the combination are lacking.

用白話說明這項交互作用的意義

Efgartigimod / hyaluronidase sc and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

證據等級: Low

為什麼會發生

FcRn blockade by efgartigimod accelerates degradation of IgG-based antibodies such as galcanezumab.

處置方式

Monitor migraine frequency and consider an alternative non-antibody preventive if control worsens. Review the need for continued galcanezumab during efgartigimod therapy.

可向藥師詢問的問題

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ 會員專屬

解鎖完整頁面

建立帳號並開始 Pro+ 試用,即可解鎖 Efgartigimod / hyaluronidase sc 與 Galcanezumab 的完整臨床處置建議、補充說明、證據詳情及整張處方的交互作用檢查工具。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

在網頁版免費試用 Pro+ 14 天,無需信用卡。

常見問題

Can I take Efgartigimod / hyaluronidase sc with Galcanezumab?

MediHelp rates the interaction as moderate. Efgartigimod / hyaluronidase sc and Galcanezumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which normally recycles IgG and prolongs its half-life. Galcanezumab is an IgG4 antibody, so exposure and migraine prevention could be reduced. Clinical data for the combination are lacking.

How serious is the interaction between Efgartigimod / hyaluronidase sc and Galcanezumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor migraine frequency and consider an alternative non-antibody preventive if control worsens. Review the need for continued galcanezumab during efgartigimod therapy.

What other medicines interact with Galcanezumab?

MediHelp also lists interactions of Galcanezumab with, for example, Efgartigimod alfa, Rozanolixizumab. The full list is on the Galcanezumab page.

在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查

在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用,並使用劑量工具。

依 A–Z 瀏覽 · 藥物交互作用

取得 App 登入